tiletamine hydrochloride has been researched along with Cancer of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MB; Jin, ZC; Wang, Y; Xu, LJ; Xu, M; Yang, DR; Zhou, LN; Zhu, J | 1 |
| Janovszky, A; Karg, E; László, A; Rózsa, M; Sallay, E; Tiszlavicz, L; Túri, S; Ugarte, M; Várkonyi, A; Wittmann, G | 1 |
| Finegold, M; Grompe, M; Lee, AY; Rothfuss, A; Sharma, AD; Vogel, A; Wang, Z; Willenbring, H | 1 |
| Berry, JM; Bradshaw, TD; Burger, AM; Seaton, A; Stevens, MF; Wang, B; Wells, G; Westwell, AD | 1 |
| Hayakawa, M; Horiguchi, Y; Ito, K; Mizuno, R; Murai, M; Oya, M; Sato, A; Umezawa, K | 1 |
| Bucher, JR; Huff, J; Kluwe, WM | 1 |
6 other study(ies) available for tiletamine hydrochloride and Cancer of Kidney
| Article | Year |
|---|---|
The therapeutic value of SC66 in human renal cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclohexanones; Female; Humans; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Mice, SCID; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinase; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
The fate of tyrosinaemic Hungarian patients before the NTBC aera.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child, Preschool; Cyclohexanones; Enzyme Inhibitors; Fatal Outcome; Homozygote; Humans; Hungary; Hydrolases; Kidney Neoplasms; Liver Neoplasms; Male; Nitrobenzoates; Treatment Outcome; Tyrosine; Tyrosinemias | 2013 |
Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Hepatectomy; Hepatocytes; Hydrolases; Kidney Diseases, Cystic; Kidney Neoplasms; Kidney Tubules, Proximal; Liver Neoplasms; Liver Regeneration; Mice; Mice, Knockout; Neoplasms; Nitrobenzoates; Tyrosinemias | 2008 |
4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines.
Topics: Algorithms; Animals; Antineoplastic Agents; Benzothiazoles; Colonic Neoplasms; Computer Simulation; Cyclohexanes; Cyclohexanones; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Structure-Activity Relationship; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.
Topics: Benzamides; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cyclohexanones; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor I; Interferon-gamma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Proteins; NF-kappa B; RNA Interference; RNA, Small Interfering; Survivin; Transfection | 2006 |
Toxicology and carcinogenesis studies of isophorone in F344 rats and B6C3F1 mice.
Topics: Administration, Oral; Animals; Body Weight; Carcinogens; Cyclohexanes; Cyclohexanones; Female; Kidney Neoplasms; Male; Mice; Neoplasms, Experimental; Rats; Rats, Inbred F344; Sex Factors; Species Specificity | 1986 |